The status of phosphorylated p38 in esophageal squamous cell carcinoma
Authors:
- 14 December 2011
- journal article
- Published by Springer Nature in Molecular Biology Reports
- Vol. 39 (5) , 5315-5321
Abstract
The p38 mitogen-activated protein kinase (MAPK) is a member of the MAPK family, which is initially found to be activated by stress stimuli, proinflammatory cytokines, and growth factors. However, its role in the pathogenesis of esophageal squamous cell carcinoma (ESCC) is largely unkown, so we investigate the role of phosphorylated p38 (p-p38) MAPK in ESCC. First of all, in vitro cell line ECa109, SB203580 as selective inhibitor of p38, can suppress the growth of esophageal cancer cell in a dose- and time-dependent way, suggesting that ECa109 cell growth and proliferation was closely associated with p-p38. Using western-blot analysis of fresh 16 paired surgically resected ESCC and matched non-tumor adjacent tissues (NAT), we showed that p-p38 was significantly expressed higher in NAT compared to ESCC. Moreover, expressions of p-p38 were further confirmed by 162 paired of formalin-fixed paraffin-embedded (FFPE) ESCC and NAT by immunohistochemistry, the same trend result was obtained through statistical analysis that there was increased expression of p-p38 in NAT as compared with ESCC (P < 0.01), and expression of p-p38 was not significantly associated with lymph nodes metastasis (P > 0.05) and ESCC differentiation degree (P > 0.05). Taken together, all the results we obtained demonstrated that p-p38 plays a key role in the malignant transformation of ESCC.Keywords
This publication has 25 references indexed in Scilit:
- Northwestern China: a place to learn more on oesophageal cancer. Part one: behavioural and environmental risk factorsEuropean Journal of Gastroenterology & Hepatology, 2010
- Positive crosstalk between ERK and p38 in melanoma stimulates migration and in vivo proliferationPigment Cell & Melanoma Research, 2009
- Activation of Growth Factor Receptors in Esophageal Cancer—Implications for TherapyThe Oncologist, 2007
- p38 Regulates Cyclooxygenase-2 in Human Mammary Epithelial Cells and Is Activated in Premalignant TissueCancer Research, 2005
- Prognostic significance of phosphorylated P38 mitogen‐activated protein kinase and HER‐2 expression in lymph node‐positive breast carcinomaCancer, 2004
- Protein Kinase C Promotes Apoptosis in LNCaP Prostate Cancer Cells through Activation of p38 MAPK and Inhibition of the Akt Survival PathwayJournal of Biological Chemistry, 2003
- Up-regulation of Vascular Endothelial Growth Factor C in Breast Cancer Cells by Heregulin-β1Journal of Biological Chemistry, 2003
- Targeting p38 MAPK inhibits multiple myeloma cell growth in the bone marrow milieuBlood, 2003
- Hepatocyte growth factor/scatter factor activates proliferation in melanoma cells through p38 MAPK, ATF-2 and cyclin D1Oncogene, 2002
- Nerve Growth Factor Inhibits Apoptosis in Memory B Lymphocytes via Inactivation of p38 MAPK, Prevention of Bcl-2 Phosphorylation, and Cytochrome c ReleaseJournal of Biological Chemistry, 2001